a public good project by the
Synthesis
Company
of California

© 2026

Burton Eisenberg | doi.page

0 works0 citations0 h-index

Burton Eisenberg

Hoag Memorial Hospital Presbyterian(US)

Publications by Year

Research Areas

Gastrointestinal Tumor Research and Treatment, Sarcoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, Gastrointestinal disorders and treatments

Most-Cited Works

→ Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors(2002)4,371 cited
→ Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor(2003)2,287 cited
→ Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT(2008)1,000 cited
→ Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors(2006)813 cited
Soft tissue sarcomas of adults: state of the translational science.(2003)
→ Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665(2008)418 cited

→ Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation(2011)

284 cited

→ Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial(2015)284 cited

→ Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall: Radiation Therapy Oncology Group Trial 9514(2006)280 cited

→ Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients(2004)274 cited